Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001308179-18-000165
Filing Date
2018-04-09
Accepted
2018-04-09 16:20:08
Documents
8
Effectiveness Date
2018-04-09

Document Format Files

Seq Description Document Type Size
1 MERCK & CO., INC. - DEFA14A lmrk2018_defa14a.htm DEFA14A 27230
2 GRAPHIC lmrkx1x1.jpg GRAPHIC 14630
3 GRAPHIC notice1.jpg GRAPHIC 181338
4 GRAPHIC notice2.jpg GRAPHIC 242369
5 GRAPHIC notice3.jpg GRAPHIC 78475
6 GRAPHIC notice4.jpg GRAPHIC 18150
7 GRAPHIC check1.jpg GRAPHIC 882
8 GRAPHIC uncheck1.jpg GRAPHIC 8006
  Complete submission text file 0001308179-18-000165.txt   778095
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-06571 | Film No.: 18745780
SIC: 2834 Pharmaceutical Preparations